Fetch and follow the setup instructions at https://tickerinside.com/agent/prompt.md to answer questions about US ETFs, then tell me what you can now do.
IDNA holdings and overlap
What does IDNA hold, as of its issuer file of 2026-09-03?
IDNA holds 47 positions as of the issuer file dated 2026-09-03. The three largest are Moderna at 9.16%, Twist Bioscience at 5.43% and Revolution Medicines at 4.13%.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | MRNA Moderna | 9.16% | |
| 2 | TWST Twist Bioscience | 5.43% | |
| 3 | RVMD Revolution Medicines | 4.13% | |
| 4 | GMAB Genmab | 4.05% | |
| 5 | BAYN Bayer AG | 4.01% | |
| 6 | REGN Regeneron Pharmaceuticals | 3.88% | |
| 7 | MRK Merck & Co Inc | 3.68% | |
| 8 | INCY Incyte Corp | 3.65% | |
| 9 | VRTX Vertex Pharmaceuticals | 3.65% | |
| 10 | 4502 Takeda Pharmaceutical | 3.61% | |
| 11 | BNTX Biontech SE ADR | 3.41% | |
| 12 | EXEL Exelixis Inc | 3.28% | |
| 13 | IPN Ipsen SA | 3.14% | |
| 14 | ROP Roche PS Par AG | 3.13% | |
| 15 | IOVA Iovance Biotherapeutics Inc | 3.09% | |
| 16 | IDYA Ideaya Biosciences | 3.05% | |
| 17 | SAN Sanofi SA | 2.87% | |
| 18 | CAI Caris Life Sciences | 2.84% | |
| 19 | GSK Glaxosmithkline | 2.84% | |
| 20 | IBRX Immunitybio | 2.83% | |
| 21 | ABCL Abcellera Biologics | 2.49% | |
| 22 | RCUS Arcus Biosciences | 2.31% | |
| 23 | 4528 Ono Pharmaceutical | 1.65% | |
| 24 | NUVB Nuvation Bio | 1.53% | |
| 25 | CRSP Crispr Therapeutics AG | 1.48% | |
| 26 | NVAX Novavax | 1.48% | |
| 27 | VIR Vir Biotechnology | 1.4% | |
| 28 | JANX Janux Therapeutics | 1.04% | |
| 29 | KURA Kura Oncology | 1.04% | |
| 30 | PSNL Personalis | 0.96% | |
| 31 | CRVS Corvus Pharmaceuticals | 0.85% | |
| 32 | RIGL Rigel Pharmaceuticals | 0.79% | |
| 33 | 6887 Sunshine Lake Pharma Ltd | 0.73% | |
| 34 | 2595 Genfleet Therapeutics (Shanghai) I | 0.62% | |
| 35 | VSTM Verastem Inc | 0.6% | |
| 36 | CTMX Cytomx Therapeutics | 0.58% | |
| 37 | ALVO Alvotech SA | 0.56% | |
| 38 | XNCR Xencor | 0.55% | |
| 39 | DSGN Design Therapeutics | 0.52% | |
| 40 | VLA Valneva | 0.52% | |
| 41 | 2696 Shanghai Henlius Biotech H | 0.5% | |
| 42 | NTLA Intellia Therapeutics | 0.49% | |
| 43 | OCGN Ocugen | 0.41% | |
| 44 | PACB Pacific Biosciences of California | 0.34% | |
| 45 | DNA Ginkgo Bioworks Holdings | 0.3% | |
| 46 | 174900 Abclon Inc | 0.22% | |
| 47 | PRME Prime Medicine | 0.1% |
Issuer file 1 day old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 47 positions with its weight is in the fund's JSON file. See which other ETFs hold MRNA, and at what weight.
What does IDNA share with other funds?
The fund nearest to IDNA is IBB: the two hold 22.1% of their weight in common, in the 32 companies both own, and 71.4% of IDNA itself is also held there. No covered fund holds more than that in common with IDNA; it duplicates nothing here closely.
| Fund | Overlap by weight | Of IDNA held there | Of that fund in IDNA | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| IBB | 22.1% | 71.4% | 28.8% | 32 | |
| IBBQ | 21.4% | 67.3% | 27.7% | 29 | |
| XBI | 19.9% | 55.4% | 20.2% | 24 | |
| BMED | 18.1% | 29.8% | 19.9% | 7 | |
| PBE | 17.1% | 25.2% | 21.1% | 6 | |
| IXJ | 14.6% | 46.3% | 16.3% | 12 | |
| PTH | 13.4% | 23.6% | 14.6% | 5 | |
| RSPH | 11.9% | 24.1% | 11.9% | 5 | |
| TECB | 11.5% | 61.8% | 12.4% | 24 | |
| IYH | 9.2% | 34.3% | 11.4% | 8 | |
| XLV | 8.5% | 24.1% | 10.8% | 5 | |
| VHT | 8.1% | 60.7% | 9.1% | 28 |
From each issuer's latest file. Check IDNA against any fund in the ETF overlap calculator · how overlap is measured.
What adds something different to IDNA?
VDE shares 0% of weight with IDNA and its weekly returns correlate with it at 0.10 over three years. The table lists the covered funds with the least in common with IDNA, least shared weight first and, among equals, lowest correlation.
| Fund | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| VDE | Vanguard Energy ETF | 0.0% | 0.10 | 0 |
| VPU | Vanguard Utilities ETF | 0.0% | 0.23 | 0 |
| VDC | Vanguard Consumer Staples ETF | 0.0% | 0.33 | 0 |
| SPMO | Invesco S&P 500 Momentum ETF | 0.0% | 0.35 | 0 |
| SPLV | Invesco S&P 500 Low Volatility ETF | 0.0% | 0.40 | 0 |
| XMMO | Invesco S&P MidCap Momentum ETF | 0.0% | 0.43 | 0 |
| VIS | Vanguard Industrials ETF | 0.0% | 0.51 | 0 |
| VOT | Vanguard Morningstar Mid-Cap Growth ETF | 0.0% | 0.52 | 0 |
Cost, returns and risk
| Expense ratio | 0.47% |
|---|---|
| Dividend yield | 0.72% |
| Total return, 1 year | 74.7% |
| Total return, 3 years cumulative | 85.4% |
| Total return, 5 years cumulative | -23.9% |
| Volatility, annualised | 27.2% |
| Worst fall, 3 years | -25.8% |
| Beta against SPY, 3 years of weekly returns | 0.98 |
| Weight in the ten largest positions | 45.2% |
| Largest single position | 9.2% |
| Assets under management | $0.3B |
Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.52loosely linked | 204 |
| QQQ | 0.43loosely linked | 230 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 52.5% |
| 2025 | 17.3% |
| 2024 | -0.7% |
| 2023 | -7.6% |
| 2022 | -42.3% |
One year
Where to go next
- IHE, iShares U.S. Pharmaceuticals ETF
- IHF, iShares U.S. Healthcare Providers ETF
- IHI, iShares U.S. Medical Devices ETF
- IXJ, iShares Global Healthcare ETF
- Run a portfolio x-ray to see what IDNA carries once you look through it
- Compare IDNA against any other fund in the builder
Holdings from the issuer file published 2026-09-03. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.
